Nuwellis Announces Reverse Stock Split
June 26, 2024 08:45 ET
|
Nuwellis, Inc.
MINNEAPOLIS, June 26, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a medical technology company focused on transforming the lives of people with fluid...
Nuwellis Secures New Patent for Innovative Pediatric Continuous Renal Replacement Therapy, Vivian™
June 25, 2024 09:00 ET
|
Nuwellis, Inc.
MINNEAPOLIS, June 25, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced the recent...
Nuwellis and DaVita Extend Supply and Collaboration Agreement Pilot Phase
June 06, 2024 09:00 ET
|
Nuwellis, Inc.
MINNEAPOLIS, June 06, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming the lives of patients with fluid overload, today...
Nuwellis Announces Expansion of Ultrafiltration Program to Pediatric Patients at One of the Largest Hospital Networks in Florida
May 14, 2024 09:00 ET
|
Nuwellis, Inc.
MINNEAPOLIS, May 14, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced the launch...
Nuwellis Announces Purchase Agreement with a 50 Hospital Network for Aquadex Ultrafiltration Therapy
May 09, 2024 09:00 ET
|
Nuwellis, Inc.
MINNEAPOLIS, May 09, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced a new...
Nuwellis, Inc. Announces First Quarter 2024 Financial Results
May 07, 2024 08:00 ET
|
Nuwellis, Inc.
MINNEAPOLIS, May 07, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today reported financial...
Nuwellis Receives USPTO Notice of Patent Allowance for Innovative Pediatric CRRT Technology
May 02, 2024 09:00 ET
|
Nuwellis, Inc.
MINNEAPOLIS, May 02, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming the lives of patients suffering from fluid overload, today...
Nuwellis Announces Closing of $2.7 Million Public Offering
April 30, 2024 18:09 ET
|
Nuwellis, Inc.
MINNEAPOLIS, April 30, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a medical technology company focused on transforming the lives of people with fluid...
Nuwellis, Inc. To Report First Quarter 2024 Financial Results on May 7, 2024
April 30, 2024 16:41 ET
|
Nuwellis, Inc.
MINNEAPOLIS, April 30, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced that it...
Nuwellis Announces Pricing of $2.7 Million Public Offering
April 26, 2024 09:17 ET
|
Nuwellis, Inc.
MINNEAPOLIS, April 26, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a medical technology company focused on transforming the lives of people with fluid...